Abstract
Polyglutamine diseases are characterized by neuronal intranuclear inclusions (NIIs) of expanded polyglutamine proteins, indicating the failure of protein degradation. UBB(+1), an aberrant form of ubiquitin, is a substrate and inhibitor of the proteasome, and was previously reported to accumulate in Alzheimer disease and other tauopathies. Here, we show accumulation of UBB(+1) in the NIIs and the cytoplasm of neurons in Huntington disease and spinocerebellar ataxia type-3, indicating inhibition of the proteasome by polyglutamine proteins in human brain. We found that UBB(+1) not only increased aggregate formation of expanded polyglutamines in neuronally differentiated cell lines, but also had a synergistic effect on apoptotic cell death due to expanded polyglutamine proteins. These findings implicate UBB(+1) as an aggravating factor in polyglutamine-induced neurodegeneration, and clearly identify an important role for the ubiquitin-proteasome system in polyglutamine diseases.
Original language | English |
---|---|
Pages (from-to) | 1803-13 |
Number of pages | 11 |
Journal | Human Molecular Genetics |
Volume | 13 |
Issue number | 16 |
DOIs | |
Publication status | Published - 15 Aug 2004 |
Keywords
- Apoptosis
- Blotting, Western
- Brain
- Cell Survival
- Cloning, Molecular
- DNA, Complementary
- Fluorescent Antibody Technique
- Heredodegenerative Disorders, Nervous System
- Humans
- Immunohistochemistry
- Inclusion Bodies
- Peptides
- Plasmids
- Transfection
- Tumor Cells, Cultured
- Ubiquitin
- Comparative Study
- Journal Article
- Research Support, Non-U.S. Gov't